Discover the Root Causes Comprehensive Cancer Panel
Early Detection. Genetic Insights. Personalized Prevention
Our advanced cancer testing combines cutting-edge blood-based and genetic tools to provide a proactive approach to early detection and personalized cancer risk management.
Key Features
Empowering Personalized Cancer Prevention Through Advanced Testing
Our comprehensive cancer testing panel provides a complete overview of cancer risk, integrating early detection and hereditary insights. Each component plays a crucial role in proactive healthcare management.
Multi-Cancer Early Detection (MCED)
Galleri® Test by GRAIL
-
A blood test
that uses methylation patterns to detect signals associated with >50
cancers -
Intended for
adults 50+ years or those at elevated risk
-
Provides a
"cancer signal detected" (or detected) result, with tissue of origin
prediction
-
FDA/AMA
Genetic Testing for Cancer Risk
Myriad®️ Cancer Panels (e.g., myRisk, MyRisk, MyRisk, DxRay)
-
Genetic
variants in 30+ genes associated with hereditary cancer risk
-
Helps
evaluate personal and family cancer risk (e.g., BRCA1/2, Lynch syndrome)
-
Identify
individuals with a significantly elevated lifetime cancer risk
-
Informs
risk-reducing strategies (screening, chemoprevention, breast reconstruction,
breast reconstruction)
-
One-time
test, usually not repeated unless new panels are indicated
Standard Tumor Markers (used selectively, not for population screening)
-
PSA
(prostate) – ASCO, FDA
-
CA 125
(ovarian)
-
CEA
-
AFP
-
CA
19-9
-
HE4 (VA) for
high-risk women or symptom evaluation